An in vitro reprogrammable antiviral RISC with size-preferential ribonuclease activity

Virology
Rustem OmarovH B Scholthof

Abstract

Infection of Nicotiana benthamiana plants with Tomato bushy stunt virus (TBSV) mutants compromised for silencing suppression induces formation of an antiviral RISC (vRISC) that can be isolated using chromatography procedures. The isolated vRISC sequence-specifically degrades TBSV RNA in vitro, its activity can be down-regulated by removing siRNAs, and re-stimulated by exogenous supply of siRNAs. vRISC is most effective at hydrolyzing the ~4.8kb genomic RNA, but less so for a ~2.2kb TBSV subgenomic mRNA (sgRNA1), while the 3' co-terminal sgRNA2 of ~0.9kb appears insensitive to vRISC cleavage. Moreover, experiments with in vitro generated 5' co-terminal viral transcripts show that RNAs of ~2.7kb are efficiently cleaved while those of ~1.1kb or shorter are unaffected. The isolated antiviral ribonuclease complex fails to degrade ~0.4kb defective interfering RNAs (DIs) in vitro, agreeing with findings that in plants DIs are not targeted by silencing.

References

Jan 1, 1994·Advances in Virus Research·M RussoG P Martelli
Oct 23, 1997·Nature·O Voinnet, D C Baulcombe
Aug 26, 1999·Trends in Genetics : TIG·A Fire
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·O VoinnetD C Baulcombe
Feb 13, 2001·The Plant Journal : for Cell and Molecular Biology·F RatcliffD C Baulcombe
Mar 10, 2001·Genes & Development·P A Sharp
May 23, 2002·Science·Ronald H A Plasterk
May 23, 2002·Science·Phillip D Zamore
Jul 12, 2002·Nature·Gregory J Hannon
Sep 11, 2002·The Plant Journal : for Cell and Molecular Biology·Yule LiuS P Dinesh-Kumar
Jan 7, 2003·Genes & Development·Guiliang TangPhillip D Zamore
Feb 18, 2004·Molecular Plant-microbe Interactions : MPMI·Rustem T OmarovHerman B Scholthof
Mar 19, 2004·Current Biology : CB·Phillip D Zamore
Apr 8, 2004·Virus Research·Braden M RothVicki B Vance
Apr 23, 2004·Trends in Plant Science·Dániel Silhavy, József Burgyán
Jun 24, 2004·Progress in Nucleic Acid Research and Molecular Biology·K Andrew White, Peter D Nagy
Jul 28, 2004·Trends in Biochemical Sciences·David C Baulcombe, Attila Molnár
Aug 19, 2004·The Plant Journal : for Cell and Molecular Biology·Tessa M Burch-SmithS P Dinesh-Kumar
Sep 17, 2004·Nature·Craig C Mello, Darryl Conte
Sep 17, 2004·Nature·Gunter Meister, Thomas Tuschl
Sep 17, 2004·Nature·David Baulcombe
Sep 17, 2004·Nature·Gregory J Hannon, John J Rossi
Feb 11, 2005·Nature Reviews. Genetics·Olivier Voinnet
Mar 7, 2006·Nature Reviews. Microbiology·Herman B Scholthof
May 26, 2006·The EMBO Journal·Lóránt LakatosJózsef Burgyán
Jun 14, 2006·Annual Review of Microbiology·Feng Li, Shou-Wei Ding
Jan 25, 2007·Proceedings of the National Academy of Sciences of the United States of America·Rustem T OmarovHerman B Scholthof
Feb 3, 2007·Journal of Virology·Vitantonio PantaleoJózsef Burgyán
Sep 26, 2008·Journal of Virology·Vitantonio Pantaleo, József Burgyán
Jun 16, 2009·Seminars in Cell & Developmental Biology·Veria Alvarado, Herman B Scholthof
Apr 7, 2010·PLoS Pathogens·Gyorgy SzittyaTamas Dalmay

❮ Previous
Next ❯

Citations

Jul 10, 2019·Plant, Cell & Environment·Jon OchoaBernardo Rodamilans
Jul 29, 2021·PLoS Pathogens·Hao HongXiaorong Tao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.